Armoiry X - Search Results

1

Digital Clinical Communication for Families and Caregivers of Children or Young People With Short- or Long-Term Conditions: Rapid Review.

Armoiry X, Sturt J, Phelps EE, Walker CL, Court R, Taggart F, Sutcliffe P, Griffiths F, Atherton H. Armoiry X, et al. J Med Internet Res. 2018 Jan 5;20(1):e5. doi: 10.2196/jmir.7999. J Med Internet Res. 2018. PMID: 29305339 Free PMC article. Review.

2

Use of 5-ALA fluorescence-guided surgery versus white-light conventional microsurgery for the resection of newly diagnosed glioblastomas (RESECT study): a French multicenter randomized phase III study.

Picart T, Pallud J, Berthiller J, Dumot C, Berhouma M, Ducray F, Armoiry X, Margier J, Guerre P, Varlet P, Meyronet D, Metellus P, Guyotat J; Members of RESECT study group:. Picart T, et al. Among authors: armoiry x. J Neurosurg. 2023 Oct 13;140(4):987-1000. doi: 10.3171/2023.7.JNS231170. Print 2024 Apr 1. J Neurosurg. 2023. PMID: 37856381 Clinical Trial.

3

Reconciling conflicting evidence in the evaluation of the MitraClip system: Assessment of and response to the MITRA-FR and COAPT trials by key stakeholders.

Montagnon M, Chen Y, Grove A, Park J, Obadia JF, Armoiry X. Montagnon M, et al. Among authors: armoiry x. J Evid Based Med. 2024 Jun;17(2):253-255. doi: 10.1111/jebm.12614. Epub 2024 May 24. J Evid Based Med. 2024. PMID: 38783795 No abstract available.

4

Potential impact on cost-effectiveness estimates of using immature survival data: a case study based on transcatheter edge-to-edge repair (TEER) used for patients with severe mitral regurgitation at high surgical risk.

Connock M, Auguste P, Capelle A, Hénaine AM, Obadia JF, Armoiry X. Connock M, et al. Among authors: armoiry x. BMJ Open. 2023 Mar 14;13(3):e060423. doi: 10.1136/bmjopen-2021-060423. BMJ Open. 2023. PMID: 36918244 Free PMC article.

5

Lower Limb Ischemia in Surgical Femoral Veno-Arterial Extracorporeal Membrane Oxygenation.

Dragulescu R, Armoiry X, Jacquet-Lagrèze M, Portran P, Schweizer R, Fellahi JL, Grinberg D, Obadia JF, Pozzi M. Dragulescu R, et al. Among authors: armoiry x. J Cardiothorac Vasc Anesth. 2023 Nov;37(11):2272-2279. doi: 10.1053/j.jvca.2023.07.025. Epub 2023 Jul 24. J Cardiothorac Vasc Anesth. 2023. PMID: 37598037

6

Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals? A case-study focusing on disease-modifying therapies for treatment of multiple sclerosis.

Armoiry X, Wang-Steverding X, Connock M, Grove A, Clarke A, Arun T, Counsell C, Auguste P. Armoiry X, et al. Int J Technol Assess Health Care. 2022 Dec 13;38(1):e83. doi: 10.1017/S0266462322003269. Int J Technol Assess Health Care. 2022. PMID: 36510406 Review.

7

Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation.

Melendez-Torres GJ, Auguste P, Armoiry X, Maheswaran H, Court R, Madan J, Kan A, Lin S, Counsell C, Patterson J, Rodrigues J, Ciccarelli O, Fraser H, Clarke A. Melendez-Torres GJ, et al. Among authors: armoiry x. Health Technol Assess. 2017 Sep;21(52):1-352. doi: 10.3310/hta21520. Health Technol Assess. 2017. PMID: 28914229 Free PMC article. Review.

8

Pembrolizumab for Previously Treated Advanced or Metastatic Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.

Gallacher D, Armoiry X, Auguste P, Court R, Mantopoulos T, Patterson J, De Santis M, Cresswell J, Mistry H. Gallacher D, et al. Among authors: armoiry x. Pharmacoeconomics. 2019 Jan;37(1):19-27. doi: 10.1007/s40273-018-0689-3. Pharmacoeconomics. 2019. PMID: 30030817 Review.

9

Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis: systematic review and network meta-analysis of trials including recommended dosages.

Melendez-Torres GJ, Armoiry X, Court R, Patterson J, Kan A, Auguste P, Madan J, Counsell C, Ciccarelli O, Clarke A. Melendez-Torres GJ, et al. Among authors: armoiry x. BMC Neurol. 2018 Oct 3;18(1):162. doi: 10.1186/s12883-018-1162-9. BMC Neurol. 2018. PMID: 30285675 Free PMC article. Review.

10

Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myeloma.

Armoiry X, Spath HM, Clarke A, Connock M, Sutcliffe P, Dussart C. Armoiry X, et al. J Mark Access Health Policy. 2019 Jul 30;7(1):1648971. doi: 10.1080/20016689.2019.1648971. eCollection 2019. J Mark Access Health Policy. 2019. PMID: 31489149 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters